Gentamicin in infective endocarditis: How to use It?

Clinical Infectious Diseases

Volumn 49, Issue 2, 2009, Pages 320-321

  Frippiat, Frederic ^a   Chandrikakumari, Kavitha ^a   Moutschen, Michel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

BACTERIAL ENDOCARDITIS; ENTEROCOCCUS; HUMAN; LETTER; MORBIDITY; MORTALITY; NEPHROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS; GENTAMICINS; HUMANS; KIDNEY;

EID: 67651108595     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/600063     Document Type: Letter

References (9)

1. Buchholtz K, Larsen CT, Hassager C, Bruun NE. Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. Clin Infect Dis 2009;48:65- 71.
2. . Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association-endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: e394-434.
3. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
4. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25:267-76.
5. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Che- mother 2004;54:971-81.
6. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995;39:650-5.
7. Olaison L, Schadewitz K, for the Swedish society of infectious diseases quality assurance study group for endocarditis. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycoside be used? Clin Infect Dis 2002;34:159-66.
8. Falagas ME, Matthaiou DK, Bliziotis JA. The role of aminoglycosides in combination with a b-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 2006; 57:639-47.
9. Cosgrove SE, Vigliani GA, Campion M, et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009;48:713-21.